BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 19026633)

  • 1. Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferation.
    Lu W; Tinsley HN; Keeton A; Qu Z; Piazza GA; Li Y
    Eur J Pharmacol; 2009 Jan; 602(1):8-14. PubMed ID: 19026633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
    Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
    Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro.
    Stakheev D; Taborska P; Strizova Z; Podrazil M; Bartunkova J; Smrz D
    Sci Rep; 2019 Mar; 9(1):4761. PubMed ID: 30886380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.
    Lu W; Lin C; Roberts MJ; Waud WR; Piazza GA; Li Y
    PLoS One; 2011; 6(12):e29290. PubMed ID: 22195040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells.
    Lu W; Lin C; King TD; Chen H; Reynolds RC; Li Y
    Cell Signal; 2012 Dec; 24(12):2291-6. PubMed ID: 22820499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens.
    Schweizer L; Rizzo CA; Spires TE; Platero JS; Wu Q; Lin TA; Gottardis MM; Attar RM
    BMC Cell Biol; 2008 Jan; 9():4. PubMed ID: 18218096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells.
    Leow PC; Tian Q; Ong ZY; Yang Z; Ee PL
    Invest New Drugs; 2010 Dec; 28(6):766-82. PubMed ID: 19730790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics.
    Bisson I; Prowse DM
    Cell Res; 2009 Jun; 19(6):683-97. PubMed ID: 19365403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibition of Wnt/β-catenin signaling pathway in human colon cancer cells by sulindac.
    Tai WP; Hu PJ; Wu J; Lin XC
    Tumori; 2014; 100(1):97-101. PubMed ID: 24675499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Wnt/β-catenin signaling mediates ursolic acid-induced apoptosis in PC-3 prostate cancer cells.
    Park JH; Kwon HY; Sohn EJ; Kim KA; Kim B; Jeong SJ; Song JH; Koo JS; Kim SH
    Pharmacol Rep; 2013; 65(5):1366-74. PubMed ID: 24399733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secreted Frizzled-related protein-1 is a negative regulator of androgen receptor activity in prostate cancer.
    Kawano Y; Diez S; Uysal-Onganer P; Darrington RS; Waxman J; Kypta RM
    Br J Cancer; 2009 Apr; 100(7):1165-74. PubMed ID: 19277043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ME-143 Is Superior to Genistein in Suppression of WNT Signaling in Colon Cancer Cells.
    Pintova S; Planutis K; Planutiene M; Holcombe RF
    Anticancer Res; 2017 Apr; 37(4):1647-1653. PubMed ID: 28373425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of WNT/beta-catenin pathway activation on signaling through T-cell factor and androgen receptor in prostate cancer cell lines.
    Cronauer MV; Schulz WA; Ackermann R; Burchardt M
    Int J Oncol; 2005 Apr; 26(4):1033-40. PubMed ID: 15753999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capsaicin suppressed activity of prostate cancer stem cells by inhibition of Wnt/β-catenin pathway.
    Zhu M; Yu X; Zheng Z; Huang J; Yang X; Shi H
    Phytother Res; 2020 Apr; 34(4):817-824. PubMed ID: 31782192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.
    Hallett RM; Kondratyev MK; Giacomelli AO; Nixon AM; Girgis-Gabardo A; Ilieva D; Hassell JA
    PLoS One; 2012; 7(3):e33976. PubMed ID: 22470504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin interrupts the interaction between the androgen receptor and Wnt/β-catenin signaling pathway in LNCaP prostate cancer cells.
    Choi HY; Lim JE; Hong JH
    Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):343-9. PubMed ID: 20680030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt/β-catenin activation promotes prostate tumor progression in a mouse model.
    Yu X; Wang Y; DeGraff DJ; Wills ML; Matusik RJ
    Oncogene; 2011 Apr; 30(16):1868-79. PubMed ID: 21151173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.
    Horvath LG; Lelliott JE; Kench JG; Lee CS; Williams ED; Saunders DN; Grygiel JJ; Sutherland RL; Henshall SM
    Prostate; 2007 Jul; 67(10):1081-90. PubMed ID: 17476687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the aqueous extract of Aloe vera and its two active components on the Wnt/β-catenin and Notch signaling pathways in colorectal cancer cells.
    Peng C; Zhang W; Dai C; Li W; Shen X; Yuan Y; Yan L; Zhang W; Yao M
    J Ethnopharmacol; 2019 Oct; 243():112092. PubMed ID: 31319122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of anti-Wnt/β-catenin signaling agents by pGL4-TOP transfected stable cells with a luciferase reporter system.
    Chuang KA; Lieu CH; Tsai WJ; Wu MH; Chen YC; Liao JF; Wang CC; Kuo YC
    Braz J Med Biol Res; 2010 Oct; 43(10):931-41. PubMed ID: 20835687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.